تصفح QU Health حسب النوع "Other"
السجلات المعروضة 1 -- 5 من 5
-
Correction to: A qualitative assessment of medical students' readiness for virtual clerkships at a Qatari university during the COVID-19 pandemic (BMC Medical Education, (2023), 23, 1, (186), 10.1186/s12909-023-04117-3)
( BioMed Central Ltd , 2023 , Other)Correction: BMC Medical Education (2023) 23:186 Following publication of the original article [1], due to a typesetting error, references [19] and [20] were written incorrectly. The correct references are given below: [19] ... -
Corrigendum to "Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study". [Current Problems in Cardiology Volume 46, Issue 6, June 2021, 100816]
( Elsevier , 2021 , Other)Authors regret an affiliation was missed for Dr. Nabil Shallik in the original version. The affiliation "Faculty of Medicine, Tanta University, Tanta, Egypt" has now been added. And also the order of authors has been ... -
Corrigendum to “Peri-renal adipose inflammation contributes to renal dysfunction in a non-obese prediabetic rat model: Role of anti-diabetic drugs” [Biochem. Pharmacol. 186 (2021) 114491]
( Elsevier , 2023 , Other)We regret to report that a mistake occurred in preparation of Fig. 4. The modified figure is included below. We apologize for any confusion this might have created. -
Editorial: Reviews in healthcare professions education
( Frontiers Media SA , 2024 , Other)Healthcare is a complex and ever-evolving field, encompassing various challenges, advancements, and intricacies that impact patient care, medical education, and clinical practice. Review articles play a crucial role in ... -
Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy
( Springer Science and Business Media B.V. , 2024 , Other)Despite the availability of technological advances in traditional anti-cancer therapies, there is a need for more precise and targeted cancer treatment strategies. The wide-ranging shortfalls of conventional anticancer ...